Shi Y, Li B, Wu L, Pan Y, et al. Efficacy and safety of Limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M mutated non-small cell lung cancer: a multicenter, single-arm, phase 2b study. J Thorac Oncol 2022 Jun 1. pii: S1556-0864(22)00267.
PMID: 35659581